To reduce the effect of disease/dataset heterogeneity on severity correlation studies, we utilized a transcriptomic dataset on matched skin biopsies repeatedly taken from the same cohort of psoriasis patients before and after therapy with the anti‐IL17R antibody Brodalumab (Russell et al, 2014). Here, IL17RA is linked to psoriasis.